Douglas Kerr - 03 Sep 2024 Form 3 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role: Chief Medical Officer
Signature: /s/ Richard Scalzo, Attorney-in-Fact
Issuer symbol: DYN
Transactions as of: 03 Sep 2024
Transactions value $: $0
Form type: 3
Filing time: 03 Sep 2024, 18:14:09 UTC
Previous filing: 31 Jan 2024
Next filing: 06 Dec 2024
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 Power of Attorney